Understand what your mental wellness results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Depression and the blood systems that shape mood
Depression biomarkers are measurable signals in blood that mirror the brain–body systems shaping mood, motivation, and energy. They capture how the stress response is operating (hypothalamic–pituitary–adrenal, HPA axis), whether the immune system is activated (systemic inflammation, cytokines), how well nerve cells support growth and connectivity (neurotrophic factors such as BDNF), and how the body manages fuel and timing (metabolic and circadian regulation). Blood testing turns these hidden processes into an objective snapshot that complements conversation and symptom scales. It can reveal when biology is pushing mood through specific pathways, help distinguish different biological “flavors” of depression, and provide a baseline to track change as treatment proceeds. By showing which levers are most perturbed for a given person—stress signaling, immune activity, neuroplasticity, or metabolism—biomarkers enable more targeted choices and clearer monitoring of recovery. In short, they translate an internal experience into a measurable profile (biological phenotype) that can inform care while working alongside clinical judgment and personal goals.
Why a biological read helps frame the clinical picture
Depression is not just a brain state; it’s a whole-body condition shaped by stress hormones, inflammation, and immune balance. Blood biomarkers help map these systems: cortisol reflects the brain–adrenal stress axis, high-sensitivity CRP (hs-CRP) captures systemic inflammatory tone, and the neutrophil-to-lymphocyte ratio (NLR) shows the balance between innate and adaptive immunity. Together, they clarify whether mood symptoms ride on stress reactivity, inflammation, or immune dysregulation. Typical morning cortisol lands around 10–20, with an optimal pattern in the mid-range and a clear drop by evening. When high, people often feel wired-tired, anxious, and sleep-fragmented; when low or flattened, energy, motivation, and stress tolerance sag. hs-CRP under 1 is generally favorable, 1–3 is average, and over 3 suggests heightened inflammation; lower values tend to be optimal. NLR usually sits near 1–3; the lower end of normal often reflects a calm immune set point, while higher values track physiological stress. Women often show slightly higher hs-CRP than men, and pregnancy raises cortisol and hs-CRP as normal adaptations; children typically have lower NLR.When these markers run low, they tell different stories. Low morning cortisol or a blunted rhythm points to underactive HPA signaling (hypocortisolism), seen in some depression subtypes, with fatigue, hypersomnia, pain sensitivity, and cognitive slowing; teens and the postpartum period may feel this as overwhelming tiredness and reduced stress resilience. Very low hs-CRP usually means minimal systemic inflammation; in depression, it suggests symptoms are driven more by neural circuitry or psychosocial load than inflammation. A markedly low NLR—often from neutropenia or relative lymphocytosis—can indicate viral illness, autoimmune activity, or medication effects, showing up as frequent infections or mouth ulcers; mood effects are typically indirect. Big picture, these markers connect mood to endocrine, immune, metabolic, and sleep systems. Persistent inflammation or stress-axis disruption links to cardiometabolic risk, pain amplification, and cognitive change over time. Tracking cortisol, hs-CRP, and NLR alongside thyroid, glucose–insulin, lipids, vitamin D/B12, and sex steroids provides a systems view of depression biology and its long-term health implications.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
What these markers can and can't tell you about depression
Depression blood testing offers a window into how your body’s stress, immune, and inflammatory systems are functioning—key players in energy, metabolism, cardiovascular health, cognition, and even immunity. At Superpower, we focus on three biomarkers: Cortisol, high-sensitivity C-reactive protein (hs-CRP), and the neutrophil-to-lymphocyte ratio (NLR). Together, these markers help reveal the biological patterns that often accompany depression. Cortisol is a hormone released in response to stress, regulating energy, metabolism, and the body’s daily rhythms. In depression, cortisol levels can be higher or more erratic, reflecting chronic stress or disrupted circadian patterns. hs-CRP is a sensitive marker of inflammation; elevated levels suggest the immune system is more active than usual, which is commonly seen in depression and linked to changes in mood and cognition. NLR measures the balance between two types of white blood cells—neutrophils and lymphocytes—offering insight into immune system activity and inflammation, both of which can shift in depressive states. Healthy stability in these biomarkers supports emotional resilience and balanced brain chemistry. When cortisol, hs-CRP, or NLR are outside typical ranges, it may signal that the body’s stress and immune responses are under strain, which can contribute to or reflect depressive symptoms. Interpretation of these results depends on context. Factors like age, pregnancy, acute illness, chronic conditions, medications, and even lab methods can influence levels. Understanding your unique situation is essential for accurate assessment.
Frequently Asked Questions
References
- Stetler C, Miller GE (2011). Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. *Psychosomatic Medicine*, *73*(2), 114-126. https://doi.org/10.1097/PSY.0b013e31820ad12b
- Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. *Psychosomatic Medicine*, *71*(2), 171-186. https://doi.org/10.1097/PSY.0b013e3181907c1b
- Miller AH, Raison CL (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. *Nature Reviews Immunology*, *16*(1), 22-34. https://doi.org/10.1038/nri.2015.5
- Mazza MG, Lucchi S, Tringali AGM, Rossetti A, Botti ER, Clerici M (2018). Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis. *Progress in Neuro-Psychopharmacology and Biological Psychiatry*, *84*(Pt A), 229-236. https://doi.org/10.1016/j.pnpbp.2018.03.012
- Kishi T, Yoshimura R, Ikuta T, Iwata N (2018). Brain-derived neurotrophic factor and major depressive disorder: Evidence from meta-analyses. *Frontiers in Psychiatry*, *8*, 308. https://doi.org/10.3389/fpsyt.2017.00308















